Using Ultrasonic Transient Elastometry (FibroScan) to Predict Esophageal Varices in Patients with Viral Liver Cirrhosis

Ultrasound in Medicine and Biology

Volumn 41, Issue 6, 2015, Pages 1530-1537

  Hu, Zhongwei ^a   Li, Yuyuan ^b   Li, Chuo ^a   Huang, Chunming ^a   Ou, Zhitao ^a   Guo, Jiawei ^a   Luo, Hongbin ^a   Tang, Xiaoping ^a  

^a Guangzhou Eighth People's Hospital   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal varices; FibroScan; Liver cirrhosis; Transient elastography

Indexed keywords

ENDOSCOPY; MEDICAL IMAGING; PLATELETS; VIRUSES;

ESOPHAGEAL VARICES; FIBROSCAN; HEPATITIS C VIRUS; LIVER CIRRHOSIS; RECEIVER OPERATING CHARACTERISTIC CURVES; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAPHY; UPPER GASTROINTESTINAL;

FORECASTING;

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; IMMUNOGLOBULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATORENAL SYNDROME; HUMAN; KIDNEY FAILURE; LEG EDEMA; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; ULTRASONIC TRANSIENT ELASTOMETRY; COMPLICATION; DEVICES; ECHOGRAPHY; ESOPHAGUS; LIVER; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; VIROLOGY;

ADULT; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGUS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84929511877     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2015.02.005     Document Type: Article

References (48)

1. Addley J., Tham T.C., Cash W.J. Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc 2012, 4:281-289.
2. Bataller R., Brenner D.A. Liver fibrosis. JClin Invest 2005, 115:209-218.
3. Benvegnù L., Gios M., Boccato S., Alberti A. Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications. Gut 2004, 53:744-749.
4. Boursier J., Zarski J.P., de Ledinghen V., Rousselet M.C., Sturm N., Lebail B., Fouchard-Hubert I., Gallois Y., Oberti F., Bertrais S., Calès P. Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013, 57:1182-1191.
5. Bureau C., Metivier S., Peron J.M., Selves J., Robic M.A., Gourraud P.A., Rouquet O., Dupuis E., Alric L., Vinel J.P. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008, 27:1261-1268.
6. Calvaruso V., Bronte F., Conte E., Simone F., Craxì A., Di Marco V. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. JViral Hepat 2013, 20:867-874.
7. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Lévy V.G., Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004, 40:652-659.
8. Castéra L., Le Bail B., Roudot-Thoraval F., Bernard P.H., Foucher J., Merrouche W., Couzigou P., de Lédinghen V. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. JHepatol 2009, 50:59-68.
9. Castera L., Pinzani M., Bosch J. Non-invasive evaluation of portal hypertension using transient elastography. JHepatol 2012, 56:696-703.
10. Castéra L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., Darriet M., Couzigou P., De Lédinghen V. Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
11. Chinese Medical Association Trial scheme of diagnosing and treating gastroesophageal varices under endoscopy. Chin J Dig Endosc 2003, 2004(21):149-151.
12. Cui X.W., Friedrich-Rust M., De Molo C., Ignee A., Schreiber-Dietrich D., Dietrich C.F. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol 2013, 19:6329-6347.
13. De Franchis R. Evolving consensus in portal hypertension: Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. JHepatol 2005, 43:167-176.
14. Di Marco V., Lo Iacono O., Cammà C., Vaccaro A., Giunta M., Martorana G., Fuschi P., Almasio P.L., Craxì A. The long-term course of chronic hepatitis B. Hepatology 1999, 30:257-264.
15. Dolmazashvili E., Zhamutashvili M., Svanidze M., Nizharadze N., Abutidze A. FibroScan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia. Georgian Med News 2008, 165:83-87.
16. Fransen van de Putte D., Blom R., van Soest H., Mundt M., Verveer C., Arends J., de Knegt R.E., Mauser-Bunschoten E., van Erpecum K. Impact of FibroScan on management of chronic viral hepatitis in clinical practice. Ann Hepatol 2011, 10:469-476.
17. Friedrich-Rust M., Rosenberg W., Parkes J., Herrmann E., Zeuzem S., Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010, 10:103.
18. Giannini E.G., Zaman A., Kreil A., Floreani A., Dulbecco P., Testa E., Sohaey R., Verhey P., Peck-Radosavljevic M., Mansi C., Savarino V., Testa R. Platelet count/spleen diameter ratio for the non-invasive diagnosis of esophageal varices: Results of a multicenter, prospective, validation study. Am J Gastroenterol 2006, 101:2511-2519.
19. Ginès P., Cárdenas A., Arroyo V., Rodés J. Management of cirrhosis and ascites. NEngl J Med 2004, 350:1646-1654.
20. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., Wang J., Chen C.S., Chen J., Wildman R.P., Klag M.J., Whelton P.K. Major causes of death among men and women in China. NEngl J Med 2005, 353:1124-1134.
21. Ikeda K., Saitoh S., Suzuki Y., Kobayashi M., Tsubota A., Koida I., Arase Y., Fukuda M., Chayama K., Murashima N., Kumada H. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. JHepatol 1998, 28:930-938.
22. Jang H.W., Kim S.U., Park J.Y., Ahn S.H., Han K.H., Chon C.Y., Park Y.N., Choi E.H., Kim D.Y. How many valid measurements are necessary to assess liver fibrosis using FibroScan in patients with chronic viral hepatitis? An analysis of patients with at least 10 valid measurements. Yonsei Med J 2012, 53:337-345.
23. Jensen D.M. Endoscopic screening for varices in cirrhosis: Findings, implications, and outcomes. Gastroenterology 2002, 122:1620-1630.
24. Kazemi F., Kettaneh A., N'kontchou G., Pinto E., Ganne-Carrie N., Trinchet J.C., Beaugrand M. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. JHepatol 2006, 45:230-235.
25. Kim B.K., Kim H.S., Park J.Y., Ahn S.H., Chon C.Y., Park Y.N., Han K.H., Kim S.U. Prospective validation of ELF test in comparison with FibroScan and FibroTest to predict liver fibrosis in Asian patients with chronic hepatitis B. PLoS One 2012, 7:e41964.
26. Kim S.U., Lee J.H., Kim D.Y., Ahn S.H., Jung K.S., Choi E.H., Park Y.N., Han K.H., Chon C.Y., Park J.Y. Prediction of liver-related events using FibroScan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012, 7:e36676.
27. Lemoine M., Katsahian S., Ziol M., Nahon P., Ganne-Carrie N., Kazemi F., Grando-Lemaire V., Trinchet J.C., Beaugrand M. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 2008, 28:1102-1110.
28. Marcellin P., Ziol M., Bedossa P., Douvin C., Poupon R., de Lédinghen V., Beaugrand M. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009, 29:242-247.
29. Margolis H.S., Alter M.J., Hadler S.C. Hepatitis B: Evolving epidemiology and implications for control. Semin Liver Dis 1991, 11:84-92.
30. Millonig G., Friedrich S., Adolf S., Fonouni H., Golriz M., Mehrabi A., Buchler M. Liver stiffness is directly influenced by central venous pressure. Ultrasound Med Biol 2010, 52:206-210.
31. Millonig G., Friedrich S., Adolf S., Poschl G., Stiefel P., Seitz H.K., Muelle S. Increased Venous pressure increases liver stiffness (FibroScan) independent of liver fibrosis. JHepatol 2009, 50:204.
32. Nguyen-Khac E., Saint-Leger P., Tramier B., Coevoet H., Capron D., Dupas J.L. Noninvasive diagnosis of large esophageal varices by FibroScan: Strong influence of the cirrhosis etiology. Alcohol Clin Exp Res 2010, 34:1146-1153.
33. Niederau C., Lange S., Heintges T., Erhardt A., Buschkamp M., Hürter D., Nawrocki M., Kruska L., Hensel F., Petry W., Häussinger D. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology 1998, 28:1687-1695.
34. Palmeri M.L., Wang M.H., Rouze N.C., Abdelmalek M.F., Guy C.D., Moser B., Diehl A.M., Nightingale K.R. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. JHepatol 2011, 55:666-672.
35. Robic M.A., Procopet B., Métivier S., Péron J.M., Selves J., Vinel J.P., Bureau C. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. JHepatol 2011, 55:1017-1024.
36. Runyon B.A. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013, 57:1651-1653.
37. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., Christidis C., Ziol M., Poulet B., Kazemi F., Beaugrand M., Palau R. Transient elastography: A new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29:1705-1713.
38. Sanyal A.J., Fontana R.J., Di Bisceglie A.M., Everhart J.E., Doherty M.C., Everson G.T., Donovan J.A., Malet P.F., Mehta S., Sheikh M.Y., Reid A.E., Ghany M.G., Gretch D.R. The prevalence and risk factors associated with esophageal varices in patients with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006, 64:855-864.
39. Sebastiani G., Tempesta D., Fattovich G., Castera L., Halfon P., Bourliere M., Noventa F., Angeli P., Saggioro A., Alberti A. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. JHepatol 2010, 53:630-638.
40. Sporea I., Sirli R., Bota S., Popescu A., Sendroiu M., Jurchis A. Comparative study concerning the value of acoustic radiation force impulse elastography (ARFI) in comparison with transient elastography (TE) for the assessment of liver fibrosis in patients with chronic hepatitis B and C. Ultrasound Med Biol 2012, 38:1310-1316.
41. Tatsumi C., Kudo M., Ueshima K., Kitai S., Takahashi S., Inoue T., Minami Y., Chung H., Maekawa K., Fujimoto K., Akiko T., Takeshi M. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology 2008, 51(Suppl 1):27-33.
42. Thabut D., Imbert-Bismut F., Cazals-Hatem D., Messous D., Muntenau M., Valla D.C., Moreau R., Poynard T., Lebrec D. Relationship between the FibroTest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 2007, 26:359-368.
43. Thabut D., Moreau R., Lebrec D. Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology 2011, 53:683-694.
44. Thabut D., Trabut J.B., Massard J., Rudler M., Muntenau M., Messous D., Poynard T. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: A preliminary retrospective study. Liver Int 2006, 26:271-278.
45. Vizzutti F., Arena U., Romanelli R.G., Rega L., Foschi M., Colagrande S., Petrarca A., Moscarella S., Belli G., Zignego A.L., Marra F., Laffi G., Pinzani M. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007, 45:1290-1297.
46. Wang L., Xing J., Chen F., Yan R., Ge L., Qin Q., Wang L., Ding Z., Guo W., Wang N. Spatial analysis on hepatitis C virus infection in mainland china: from 2005 to 2011. PLoS One 2014, 9:e110861.
47. Yeh J.L., Peng Y.C., Tung C.F., Yang D.Y., Hu W.H., Chow W.K., Yeh H.Z., Chen G.H. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma. Hepatogastroenterology 2003, 50:1603-1608.
48. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., de Lédinghen V., Marcellin P., Dhumeaux D., Trinchet J.C., Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.